BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 25921970)

  • 21. The Role of TIPS in patients with Refractory Ascites and Portal Vein Thrombosis.
    Chinchilla-López P; Hamdan-Pérez N; Guerrero-Ixtlahuac J; Barranco-Fragoso B; Méndez-Sánchez N
    Ann Hepatol; 2017; 16(4):619-620. PubMed ID: 28611269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of early antiplatelet therapy after splenectomy with gastro-oesophageal devascularization.
    Zhou JB; Luo BY; Liu CW; Zhu F
    ANZ J Surg; 2018 Oct; 88(10):E725-E729. PubMed ID: 29396900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
    Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.
    Faccia M; Ainora ME; Ponziani FR; Riccardi L; Garcovich M; Gasbarrini A; Pompili M; Zocco MA
    World J Gastroenterol; 2019 Aug; 25(31):4437-4451. PubMed ID: 31496623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of portal vein system thrombosis after laparoscopic splenectomy and azygoportal disconnection: A Retrospective Cohort Study of 75 Consecutive Patients with 3-months follow-up.
    Jiang GQ; Bai DS; Chen P; Xia BL; Qian JJ; Jin SJ
    Int J Surg; 2016 Jun; 30():143-9. PubMed ID: 27154616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
    Salem R; Vouche M; Baker T; Herrero JI; Caicedo JC; Fryer J; Hickey R; Habib A; Abecassis M; Koller F; Vogelzang R; Desai K; Thornburg B; Hohlastos E; Resnick S; Lewandowski RJ; Sato K; Ryu RK; Ganger D; Kulik L
    Transplantation; 2015 Nov; 99(11):2347-55. PubMed ID: 25905983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.
    Andring B; Kalva SP; Sutphin P; Srinivasa R; Anene A; Burrell M; Xi Y; Pillai AK
    World J Gastroenterol; 2015 Jul; 21(26):8110-7. PubMed ID: 26185383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of portal thrombosis in liver cirrhosis].
    Seijo S; García-Criado A; Darnell A; García-Pagán JC
    Gastroenterol Hepatol; 2012 Nov; 35(9):660-6. PubMed ID: 22534116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.
    Thornburg B; Desai K; Hickey R; Kulik L; Ganger D; Baker T; Abecassis M; Lewandowski RJ; Salem R
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):52-60. PubMed ID: 26997089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
    Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis.
    Uflacker R
    Tech Vasc Interv Radiol; 2003 Mar; 6(1):59-69. PubMed ID: 12772131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portal Vein Thrombosis in Cirrhosis.
    Loudin M; Ahn J
    J Clin Gastroenterol; 2017 Aug; 51(7):579-585. PubMed ID: 28489645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of Transjugular Intrahepatic Portosystemic Shunt Placement for Maintaining Portal Vein Patency in Candidates on Wait Lists Who Develop Thrombus.
    Alani M; Rowley M; Kang P; Chen S; Hirsch K; Seetharam A
    Exp Clin Transplant; 2020 Dec; 18(7):808-813. PubMed ID: 31830878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of alprostadil in prevention of portal vein thrombogenesis after splenectomy and devascularization: a clinical observation of 76 patients with portal hypertension].
    Ma JC; Zhao J; Su QH; Zhang DH; Guo Y; Ji ZZ
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):524-6. PubMed ID: 18649766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
    Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
    Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.